PharmaCann International is a leading company in the ﬁeld of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, Pharmacann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
Pharmacann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication.
Pharmacann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.